Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $109
Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $109
Needham維持對Merit Medical Systems的買入評級，將目標股價上調至109美元
Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $105 to $109.
Needham分析師Mike Matson維持對Merit Medical Systems (NASDAQ:MMSI)的買入評級，並將價格目標從$105上調至$109。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間